Examining lung cancer screening utilization with public-use data: Opportunities and challenges

Prev Med. 2021 Jun:147:106503. doi: 10.1016/j.ypmed.2021.106503. Epub 2021 Mar 3.

Abstract

Lung cancer screening with low-dose computed tomography is recommended for high-risk smokers who meet specific eligibility criteria. Current guidelines suggest that eligible adults with a heavy smoking history will benefit from annual low dose computed tomography but due to several associated risks (e.g., false-positives, radiation exposure, overdiagnosis) a shared decision-making consultation is required by the Centers for Medicare & Medicaid Services, and endorsed by the United States Preventive Services Task Force. In order to examine potential for tracking LCS uptake, adherence, and patient-provider communication at a national level, we reviewed four regularly publicly available national surveys (National Health Interview Survey [NHIS], Behavioral Risk Factor Surveillance System [BRFSS], National Health and Nutrition Examination Survey [NHANES], and Health Information National Trends Survey [HINTS]) to assess available data; an overview of 37 publications using these sources is also provided. The results show that none of the surveys include items that fully assess current LCS guidelines. Implications for future research-including the potential to examine factors associated with LCS uptake and patient-provider communication-are addressed.

Keywords: Lung cancer screening; National datasets; Patient-provider communication; Review article; Secondary analysis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adult
  • Aged
  • Early Detection of Cancer*
  • Humans
  • Lung Neoplasms* / diagnosis
  • Medicare
  • Nutrition Surveys
  • Tomography, X-Ray Computed
  • United States